| Full Name | Holly Zehfus |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 527 Gott Rd, Enid, Oklahoma |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073076246 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 39520 (Oklahoma) | Primary |
| Entity Name | Nes Oklahoma, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528040722 PECOS PAC ID: 1456264324 Enrollment ID: O20040726000516 |
News Archive
Results of the MR WITNESS study suggest that magnetic resonance imaging may be able to identify patients with strokes that can be treated with tissue plasminogen activator, even if the time of symptom onset is unknown.
Two separate studies in mice suggest that a class of interferons being evaluated in clinical trials as a therapy for COVID-19 may increase susceptibility to bacterial infections, depending on how long patients are exposed to it, and when they receive it.
The FRS Company, a developer and distributor of FRS® Healthy Energy® products, announced today that it has received $23.1 million in its latest financing round led by Oak Investment Partners, LLC. Oak Investment Partners was an early investor in The FRS Company, and its continued support of FRS validates the company's aggressive business strategy for national and international expansion and explosive sales growth.
PolyTouch Medical Ltd., a leading developer of laparoscopic hernia mesh placement technologies, today announced that it has filed a Premarket 510(k) Application with the US Food and Drug Administration for PatchAssist, an Innovative Laparoscopic Mesh Deployment and Placement Device that enables accurate mesh placement in laparoscopic ventral hernia repair potentially reducing procedure time by 30%-50%.
An international research team led by cell biologists at the University of California, Riverside has uncovered a new insight into colon cancer, the third leading cause of cancer-related deaths in the United States. The research provides potential new avenues for diagnosing and treating the disease.
› Verified 5 days ago
| Entity Name | Emergency Services Of Oklahoma Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215249891 PECOS PAC ID: 8123209012 Enrollment ID: O20110225000085 |
News Archive
Results of the MR WITNESS study suggest that magnetic resonance imaging may be able to identify patients with strokes that can be treated with tissue plasminogen activator, even if the time of symptom onset is unknown.
Two separate studies in mice suggest that a class of interferons being evaluated in clinical trials as a therapy for COVID-19 may increase susceptibility to bacterial infections, depending on how long patients are exposed to it, and when they receive it.
The FRS Company, a developer and distributor of FRS® Healthy Energy® products, announced today that it has received $23.1 million in its latest financing round led by Oak Investment Partners, LLC. Oak Investment Partners was an early investor in The FRS Company, and its continued support of FRS validates the company's aggressive business strategy for national and international expansion and explosive sales growth.
PolyTouch Medical Ltd., a leading developer of laparoscopic hernia mesh placement technologies, today announced that it has filed a Premarket 510(k) Application with the US Food and Drug Administration for PatchAssist, an Innovative Laparoscopic Mesh Deployment and Placement Device that enables accurate mesh placement in laparoscopic ventral hernia repair potentially reducing procedure time by 30%-50%.
An international research team led by cell biologists at the University of California, Riverside has uncovered a new insight into colon cancer, the third leading cause of cancer-related deaths in the United States. The research provides potential new avenues for diagnosing and treating the disease.
› Verified 5 days ago
| Entity Name | Rokem Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538856091 PECOS PAC ID: 9032577853 Enrollment ID: O20230626002682 |
News Archive
Results of the MR WITNESS study suggest that magnetic resonance imaging may be able to identify patients with strokes that can be treated with tissue plasminogen activator, even if the time of symptom onset is unknown.
Two separate studies in mice suggest that a class of interferons being evaluated in clinical trials as a therapy for COVID-19 may increase susceptibility to bacterial infections, depending on how long patients are exposed to it, and when they receive it.
The FRS Company, a developer and distributor of FRS® Healthy Energy® products, announced today that it has received $23.1 million in its latest financing round led by Oak Investment Partners, LLC. Oak Investment Partners was an early investor in The FRS Company, and its continued support of FRS validates the company's aggressive business strategy for national and international expansion and explosive sales growth.
PolyTouch Medical Ltd., a leading developer of laparoscopic hernia mesh placement technologies, today announced that it has filed a Premarket 510(k) Application with the US Food and Drug Administration for PatchAssist, an Innovative Laparoscopic Mesh Deployment and Placement Device that enables accurate mesh placement in laparoscopic ventral hernia repair potentially reducing procedure time by 30%-50%.
An international research team led by cell biologists at the University of California, Riverside has uncovered a new insight into colon cancer, the third leading cause of cancer-related deaths in the United States. The research provides potential new avenues for diagnosing and treating the disease.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Holly Zehfus, MD 3691 Rutger St, Saint Louis, MO 63110-2515 Ph: () - | Holly Zehfus, MD 527 Gott Rd, Enid, OK 73705-5103 Ph: (580) 213-7418 |
News Archive
Results of the MR WITNESS study suggest that magnetic resonance imaging may be able to identify patients with strokes that can be treated with tissue plasminogen activator, even if the time of symptom onset is unknown.
Two separate studies in mice suggest that a class of interferons being evaluated in clinical trials as a therapy for COVID-19 may increase susceptibility to bacterial infections, depending on how long patients are exposed to it, and when they receive it.
The FRS Company, a developer and distributor of FRS® Healthy Energy® products, announced today that it has received $23.1 million in its latest financing round led by Oak Investment Partners, LLC. Oak Investment Partners was an early investor in The FRS Company, and its continued support of FRS validates the company's aggressive business strategy for national and international expansion and explosive sales growth.
PolyTouch Medical Ltd., a leading developer of laparoscopic hernia mesh placement technologies, today announced that it has filed a Premarket 510(k) Application with the US Food and Drug Administration for PatchAssist, an Innovative Laparoscopic Mesh Deployment and Placement Device that enables accurate mesh placement in laparoscopic ventral hernia repair potentially reducing procedure time by 30%-50%.
An international research team led by cell biologists at the University of California, Riverside has uncovered a new insight into colon cancer, the third leading cause of cancer-related deaths in the United States. The research provides potential new avenues for diagnosing and treating the disease.
› Verified 5 days ago
Steven Ross Mareburger, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 707 S. Monroe Street, Emergency Department, Enid, OK 73701 Phone: 580-548-1367 Fax: 580-548-1537 | |
Brian W. Cook, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 S Monroe St, Enid, OK 73701 Phone: 580-233-2300 Fax: 580-548-1489 | |
John Price, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 305 S 5th St, Enid, OK 73701 Phone: 580-233-6100 | |
John W Ronck, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 305 S 5th St, Wound Care Dept, Enid, OK 73701 Phone: 580-548-5010 Fax: 580-548-5012 | |
Dr. Michael L. Lawrence, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 310 E Owen K Garriott Rd, Enid, OK 73701 Phone: 580-249-3795 Fax: 580-234-3299 | |
Jeffrey G Hoffsommer, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 231 S 30th St, Enid, OK 73701 Phone: 580-233-2900 Fax: 580-233-2902 |